Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipocalin 1 pseudogene 1 (LCN1P1) is a pseudogene related to the lipocalin gene family, located on human chromosome 9. It is not believed to code for a functional protein; pseudogenes are typically inactive genetic sequences that resemble functional genes but lack the ability to produce a protein product. Although LCN1P1 is predicted to have small molecule binding activity and is located in the extracellular space, there is no evidence it produces an expressed or biologically active protein in humans. No therapeutic, diagnostic, or disease associations have been established for LCN1P1[2].\n\nMolecular classification: LCN1P1 is not an enzyme, receptor, transporter, or transcription factor—its primary classification is as a non-functional (processed) pseudogene of the lipocalin family[2].\nBiological functions and disease roles: No biological function or disease association is reported or suspected, in contrast to the functional protein-coding LCN1 gene, which is involved in extracellular transport of small hydrophobic molecules in tears[2][3].\nPharmacology: No drugs, mechanisms of action, biomarkers, or safety concerns are associated with LCN1P1, as it does not encode an active protein[2].\n\nSummary: LCN1P1 is not a therapeutic target, but a genomic relic of the lipocalin family; only the related LCN1 gene encodes an active protein with physiological and clinical relevance[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipocalin 1 pseudogene 1 (LCN1P1).